AgomAb Therapeutics NV Statistics
Total Valuation
AGMB has a market cap or net worth of $486.57 million. The enterprise value is $351.24 million.
| Market Cap | 486.57M |
| Enterprise Value | 351.24M |
Important Dates
The last earnings date was Thursday, April 23, 2026, after market close.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AGMB has 49.25 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 49.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 44.22% |
| Float | 16.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.52 |
| Quick Ratio | 6.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -987.92 |
Financial Efficiency
Return on equity (ROE) is -39.22% and return on invested capital (ROIC) is -23.03%.
| Return on Equity (ROE) | -39.22% |
| Return on Assets (ROA) | -20.58% |
| Return on Invested Capital (ROIC) | -23.03% |
| Return on Capital Employed (ROCE) | -43.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.47M |
| Employee Count | 62 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.46 |
| Average Volume (20 Days) | 81,126 |
Short Selling Information
The latest short interest is 791,046, so 1.94% of the outstanding shares have been sold short.
| Short Interest | 791,046 |
| Short Previous Month | 771,266 |
| Short % of Shares Out | 1.94% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.87 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -69.60M |
| Pretax Income | -73.44M |
| Net Income | -91.00M |
| EBITDA | -69.12M |
| EBIT | -69.60M |
| Earnings Per Share (EPS) | -$168.16 |
Balance Sheet
The company has $136.80 million in cash and $1.47 million in debt, with a net cash position of $135.33 million or $2.75 per share.
| Cash & Cash Equivalents | 136.80M |
| Total Debt | 1.47M |
| Net Cash | 135.33M |
| Net Cash Per Share | $2.75 |
| Equity (Book Value) | 153.69M |
| Book Value Per Share | -4.02 |
| Working Capital | 120.52M |
Cash Flow
In the last 12 months, operating cash flow was -$60.75 million and capital expenditures -$4,696, giving a free cash flow of -$59.90 million.
| Operating Cash Flow | -60.75M |
| Capital Expenditures | -4,696 |
| Depreciation & Amortization | 466,113 |
| Net Borrowing | -391,257 |
| Free Cash Flow | -59.90M |
| FCF Per Share | -$1.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AGMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -18.70% |
| FCF Yield | -12.31% |
Analyst Forecast
The average price target for AGMB is $32.00, which is 223.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.00 |
| Price Target Difference | 223.89% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |